Atorvastatin Calcium
NDC 42385-943, Atorvastatin Calcium, tablet, film coated, from Laurus Labs Limited.
- Product NDC
- 42385-943
- Status
- Listed
- Labeler
- Laurus Labs Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214513
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42385-943 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATORVASTATIN CALCIUM TRIHYDRATE80 mg/1
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42385-943-01 | 42385094301 | 100 TABLET, FILM COATED in 1 BOTTLE (42385-943-01) |
| 42385-943-05 | 42385094305 | 500 TABLET, FILM COATED in 1 BOTTLE (42385-943-05) |
| 42385-943-11 | 42385094311 | 1000 TABLET, FILM COATED in 1 BOTTLE (42385-943-11) |
| 42385-943-30 | 42385094330 | 30 TABLET, FILM COATED in 1 BOTTLE (42385-943-30) |
| 42385-943-64 | 42385094364 | 8 BLISTER PACK in 1 CARTON (42385-943-64) / 8 TABLET, FILM COATED in 1 BLISTER PACK (42385-943-08) |
| 42385-943-68 | 42385094368 | 10 BLISTER PACK in 1 CARTON (42385-943-68) / 10 TABLET, FILM COATED in 1 BLISTER PACK (42385-943-10) |
| 42385-943-90 | 42385094390 | 90 TABLET, FILM COATED in 1 BOTTLE (42385-943-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9f8ca507-b784-4d18-8d3e-d7d68072c416NADAC price for package 42385094301
GET /v1/drugs/nadac/42385094301NADAC price for package 42385094305
GET /v1/drugs/nadac/42385094305NADAC price for package 42385094311
GET /v1/drugs/nadac/42385094311NADAC price for package 42385094390
GET /v1/drugs/nadac/42385094390
Use it
Look up 42385-943 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42385-943 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42385-943. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.